We are live on ! Find out more
MEDP icon

Medpace

225 hedge funds and large institutions have $1.97B invested in Medpace in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 99 increasing their positions, 60 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 60

20% more capital invested

Capital invested by funds: $1.64B → $1.97B (+$329M)

6.8% more ownership

Funds ownership: 78.04%84.84% (+6.8%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

6% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 33

3% less funds holding

Funds holding: 231225 (-6)

52% less call options, than puts

Call options by funds: $4.18M | Put options by funds: $8.65M

Holders
225
Holders Change
-6
Holders Change %
-2.6%
% of All Funds
4.89%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
31
Increased
99
Reduced
60
Closed
33
Calls
$4.18M
Puts
$8.65M
Net Calls
-$4.46M
Net Calls Change
-$4.48M

MEDP Hedge Fund Activity: Q2 2019 in Review

225 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2019, worth a combined $1.97B — up 20% from $1.64B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of MEDP and 31 opened new positions — a net loss of 2 holders — while 60 trimmed existing stakes and 99 added.

The largest buyer was Blue Harbour Group, opening a new position worth an estimated $41.8M. The largest seller was Ameriprise, cutting an estimated $15.1M.

  • 225 institutional investors held Medpace (MEDP) as of Q2 2019, down from 231 in Q1 2019.
  • Funds reported $1.97B of Medpace stock for Q2 2019, up 20% quarter-over-quarter.
  • 31 funds opened new Medpace positions in Q2 2019 and 33 closed out, a net change of -2 holders.
  • The largest Medpace buyer in Q2 2019 was Blue Harbour Group, an estimated $41.8M added.
  • The largest Medpace seller in Q2 2019 was Ameriprise, an estimated $15.1M sold.

Based on aggregated 13F filings for Q2 2019.